Introduction to Medical Software - 11.4 | Navigating AI/ML Regulations: Global Guidance for Medical Software Course

In this lesson, we delve into the evolving landscape of regulatory guidance for artificial intelligence and machine learning in medical software. As AI/ML technologies hold immense promise for healthcare, regulators worldwide are grappling with the challenge of fostering innovation while ensuring patient safety, particularly concerning self-updating algorithms and the critical role of data management. We explore various international frameworks and the complexities of ensuring robust, explainable AI in medical applications. 🎯 Learning Objectives • Understand the regulatory challenges associated with AI/ML in medical software, balancing innovation with patient safety. • Identify key aspects of international regulatory guidance from Germany, China, and the FDA, including AI life cycle, data management, and validation. • Differentiate between interpretable AI and explainable AI in the context of regulatory requirements like the GDPR’s “right to an explanation.” • Recognize the paradigm shift from code to data as the most critical aspect in developing and regulating machine learning models. • Explain the importance of robust testing and validation strategies for AI/ML algorithms, including prospective vs. retrospective trials and independent evaluation.